Have a personal or library account? Click to login
Evaluation of Three Accelerometer Devices for Physical Activity Measurement Amongst South Asians and Europeans Cover

Evaluation of Three Accelerometer Devices for Physical Activity Measurement Amongst South Asians and Europeans

Open Access
|Jan 2020

Figures & Tables

Table 1

Clinical characteristics of participants. Results are presented as mean (SD) for continuous variables or as percentage for categorical variables. P values are for the difference between south Asians and Europeans, calculated by regression analysis with adjustment for age and gender.

EuropeansSouth Asiansp
Age (years)52.0 (13.7)50.1 (12.6)0.2
Male %55.5%60.5%0.3
Type 2 Diabetes (%)5.7%12.8%0.01
Hypertension (%)23.2.0%39.9%0.001
CHD (%)6.7%15.8%0.006
Smoking (%)42.1%24.1%<0.001
Height (cm)168.7 (10.8)164.7 (8.6)0.002
Weight (cm)75.4 (17.0)75.2 (12.0)0.9
Body mass index (kg/m2)27.0 (5.9)27.7 (3.9)0.5
Waist circumference (cm)90.4 (13.9)94.4 (11.0)0.003
Hip circumference (cm)103.7 (10.7)104.0 (8.4)0.8
Waist hip ratio0.87 (0.07)0.91 (0.09)<0.001
Time on treadmill (minutes)9.38.00.01
paah-4-1-46-g1.png
Figure 1

Bland-Altman plot for comparing the agreement between physical activity energy expenditure (METs) calculated by accelerometers (Measured) and the ETT (Actual). The difference of estimate of moderate physical activity from the Measured and the Actual (y-axis) are depicted in relation to the mean of estimates of physical activity from the Measured and the Actual (x-axis).

paah-4-1-46-g2.png
Figure 2

Mean difference between Measured (from the accelerometery device) and Actual (from the ETT) energy expenditure during rest and active stages of graded exercise test. (Red square: Actigraph GT3X+; Blue circle: Geneactiv; green triangle; Actiheart).

Table 2

Mean difference between Measured (from the accelerometery device) and Actual (from the treadmill test) energy expenditure (METs) during graded exercise test. P-values are for the difference between Measured and Actual (paired samples t-test).

DeviceStage 1(4.6 Mets)Stage 2(7.0 Mets)Stage 3(10.1 Mets)Stage 4(13.4 Mets)Phet*
Actigraph-GT3X+
Ankle–0.91 (1.08)–2.03 (1.03)–3.81 (1.19)–6.52 (1.77)0.8
Waist–2.45 (0.44)–3.95 (0.66)–6.02 (0.81)–8.46 (1.29)0.7
Hand–3.03 (0.46)–5.33 (0.49)–8.29 (0.52)–11.17 (1.03)0.9
Geneactiv
Ankle–2.34 (0.43)–3.73 (0.54)–5.87 (0.75)–8.17 (1.19)0.7
Waist–2.78 (0.14)–4.80 (0.18)–7.45 (0.29)–10.24 (0.64)0.7
Hand–2.86 (0.19)–5.18 (0.34)–8.19 (0.56)–11.21 (1.10)0.8
Actiheart
Chest–2.55 (0.66)–4.03 (0.86)–6.35 (0.89)–9.09 (1.43)0.7

[i] All P-values for difference between Measured and Actual MET.minutes: P < 0.001.

* Phet represents p-value for comparison of differences between South Asians and Europeans.

Table 3

Impact of age, gender, ethnicity and anthropometric measurements on the relationship between Measured (from the accelerometer) and Actual (from the treadmill test) energy expenditure. Results are presented as Beta (95% CI). Beta coefficients represent the relationship between Measured and Actual energy expenditure, before and after adjusting for the respective clinical variable. P values are calculated by regression analysis with adjustment for age, gender and ethnicity. Statistical significance inferred at P < 0.001 (i.e. P < 0.05 after conservative Bonferroni correction for multiple testing).

WaistWristAnkleChest
ActigraphGeneactivActigraphGeneactivActigraphGeneactivActiheart
Accelerometer2.38 (2.25_2.51)5.58 (5.29_5.87)3.00 (2.44_3.57)3.65 (3.01_4.30)1.43 (1.34_1.51)2.51 (2.38_2.64)2.28 (2.11_2.46)
Age2.40 (2.27_2.54)5.57 (5.28_5.86)3.02 (2.43_3.60)3.61 (2.95_4.26)1.43 (1.35_1.52)2.50 (2.37_2.63)2.27 (2.10_2.45)
Sex2.40 (2.27_2.54)5.57 (5.28_5.86)3.01 (2.42_3.59)3.65 (3.00_4.31)1.44 (1.35_1.52)2.50 (2.37_2.63)2.27 (2.10_2.45)
Ethnicity2.40 (2.27_2.54)5.57 (5.28_5.86)3.01 (2.42_3.59)3.65 (3.00_4.31)1.44 (1.35_1.52)2.50 (2.37_2.63)2.27 (2.10_2.45)
Height2.40 (2.27_2.54)5.59 (5.31_5.88)3.00 (2.42_3.59)3.66 (3.01_4.32)1.44 (1.35_1.53)2.50 (2.37_2.63)2.28 (2.11_2.45)
Weight2.40 (2.27_2.54)5.57 (5.28_5.87)3.01 (2.43_3.60)3.63 (2.98_4.29)1.43 (1.35_1.52)2.50 (2.37_2.63)2.31 (2.14_2.48)
Body mass index2.40 (2.27_2.54)5.57 (5.28_5.87)3.01 (2.43_3.60)3.63 (2.98_4.29)1.43 (1.35_1.52)2.50 (2.37_2.63)2.31 (2.14_2.48)
Waist2.40 (2.26_2.53)5.56 (5.27_5.85)3.02 (2.43_3.60)3.61 (2.96_4.27)1.43 (1.34_1.52)2.50 (2.37_2.63)2.34 (2.17_2.51)
Hip2.41 (2.27_2.54)5.58 (5.29_5.87)3.04 (2.46_3.62)3.64 (2.98_4.29)1.44 (1.35_1.52)2.51 (2.38_2.64)2.33 (2.16_2.50)
Waist hip ratio2.40 (2.26_2.53)5.55 (5.27_5.84)2.99 (2.40_3.57)3.63 (2.98_4.29)1.43 (1.35_1.52)2.49 (2.37_2.62)2.28 (2.10_2.45)
Smoking2.40 (2.27_2.54)5.57 (5.28_5.86)3.04 (2.45_3.62)3.70 (3.04_4.35)1.44 (1.35_1.53)2.50 (2.37_2.63)2.27 (2.10_2.45)
Functional status2.41 (2.27_2.54)5.57 (5.28_5.86)3.06 (2.47_3.65)3.73 (3.08_4.38)1.44 (1.35_1.53)2.50 (2.37_2.63)2.28 (2.10_2.46)
Angina2.40 (2.26_2.53)5.56 (5.27_5.85)3.02 (2.43_3.60)3.64 (2.98_4.29)1.44 (1.35_1.53)2.50 (2.37_2.63)2.27 (2.09_2.44)
Myocardial Infarction2.41 (2.27_2.54)5.59 (5.30_5.88)3.05 (2.46_3.63)3.65 (3.00_4.31)1.44 (1.35_1.53)2.50 (2.37_2.63)2.27 (2.10_2.45)
CABG/PCI2.40 (2.27_2.54)5.57 (5.28_5.86)3.04 (2.45_3.63)3.66 (3.00_4.31)1.44 (1.35_1.53)2.50 (2.37_2.63)2.27 (2.10_2.45)
Type 2 Diabetes2.40 (2.27_2.54)5.56 (5.28_5.85)3.00 (2.42_3.59)3.64 (2.99_4.30)1.44 (1.35_1.52)2.50 (2.37_2.63)2.27 (2.10_2.45)
Hypertension2.40 (2.26_2.53)5.56 (5.27_5.85)3.00 (2.42_3.59)3.65 (3.00_4.30)1.44 (1.35_1.53)2.53 (2.40_2.66)2.27 (2.09_2.44)

[i] Results are presented as Beta (95%CI). Beta coefficient represents the change in Actual METs per unit change in Measured METs.

DOI: https://doi.org/10.5334/paah.46 | Journal eISSN: 2515-2270
Language: English
Submitted on: Nov 12, 2019
Accepted on: Dec 8, 2019
Published on: Jan 6, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Saima Afaq, Marie Loh, Jaspal Kooner, John Chambers, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.